EKR Therapeutics makes appointment
This article was originally published in Scrip
Executive Summary
EKR Therapeutics (US), a speciality pharmaceutical company focused on the commercialisation of acute-care hospital products, has appointed its executive chairman, John Bailye, as interim president and chief executive officer. He replaces Howard Weisman, who is no longer with the company.